Delayed Diagnosis and Successful Glue Embolization of a Post-Traumatic Bronchial Artery Pseudoaneurysm: A Case Report.

Bronchial artery pseudoaneurysms (BAPs) are rare but potentially fatal vascular anomalies. We present a case of a 21-year-old male soldier who developed a BAP following a fall sustained during a suicide attempt. The BAP was identified on computed tomography angiography (CTA) and successfully treated with trans-arterial glue embolization. The patient's recovery was uncomplicated. To our knowledge, only one prior case of post-traumatic BAP treated with endovascular intervention has been reported in the literature (29 years ago). Due to the risk of significant morbidity and mortality associated with BAP rupture, prompt diagnosis and treatment are crucial. Endovascular embolization is a safe and effective treatment option for BAPs. This case highlights the effectiveness of glue embolization as a treatment modality for BAPs.

Role of Lymphatic Embolization in Chylothorax Associated with Gorham-Stout Disease: A Case Report.

A 45-year-old male patient with spontaneous chylothorax and osteolysis in the right 1st and 2nd ribs was diagnosed with Gorham-Stout disease based on clinical manifestations and bone biopsy. The chylothorax temporarily decreased after a successful selective lymphatic embolization. The patient presented with recurrent chylothorax, mild chest discomfort, and progressive osteolysis (despite administering sirolimus) during the follow-up period of 15 months.

Recanalization of Portal Vein Graft Occlusion via a Percutaneous Transmesenteric Approach: A Case Report.

Interventional recanalization is an effective treatment option for postoperative portal vein occlusion. A transhepatic or transsplenic approach is preferred, whereas a percutaneous transmesenteric route enables antegrade cannulation. Here, we present a case of successful percutaneous transmesenteric recanalization in a patient with a postoperative portal vein graft occlusion.

Primary spontaneous pneumomediastinum: 237 cases in a single-center experience over a 10-year period and assessment of factors related with recurrence.

OBJECTIVE: To evaluate the precipitating factors and symptoms of primary spontaneous pneumomediastinum (PSPM) and to assess the factors related with recurrent spontaneous pneumomediastinum (RSPM). METHODS: From 2010 to 2021, 237 PSPM patients were included in this retrospective study. Clinical information including in-hospital periods, morbidity, mortality, presenting symptoms, precipitating events, smoking, and asthma history was obtained. The patients with smoking history were subdivided into "ex-smoker" or "current smoker". The severity of asthma was categorized into "mild intermittent", "mild persistent", "moderate persistent", or "severe persistent". During follow-up, patients with RSPM were classified into "recurrence" group and the others were into "no recurrence" group. Multivariate regression analysis was used to elucidate the associated factors with RSPM. RESULTS: The mean age of study patients (men: women = 222: 15) was 23.4 years and mean period of hospital stay was 7.5 days. There was no mortality and morbidity. Most frequent symptom and precipitating factor were acute chest pain (n = 211, 89.0%) and cough (n = 72, 30.4%), respectively. RSPM occurred in 11 patients (4.6%). The proportion of patients with smoking (72.8% vs. 37.1%, p = 0.010) or asthma (81.8% vs. 39.8%, p<0.001) was significantly higher in "recurrence" group than "no recurrence" group. On multivariate analysis, asthma was the only factor associated with RSPM (mild intermittent/persistent, OR = 7.092, p = 0.047; moderate persistent, OR = 8.000, p = 0.011). CONCLUSION: PSPM is a benign disease with no morbidity and mortality. Asthma may be the associated factor with RSPM; thus, despite the low rate of recurrence, patients with asthma should be informed about the chance of RSPM.

Thrombus volume and Hounsfield unit density as a predictor of pulmonary embolism in patients with deep vein thrombosis.

BACKGROUND: There is a lack of studies evaluating the association between thrombus volume and density of deep vein thrombosis (DVT) and pulmonary embolism (PE). PURPOSE: To assess the clinical value of thrombus volume and density for prediction of PE in patients with DVT. MATERIAL AND METHODS: Among the patients with DVT, those without PE were classified as the "DVT-only group" and those with PE were classified as the "DVT-PE group." Thrombus volume and Hounsfield unit (HU) density of DVT was measured by drawing free-hand volume of interests within the thrombus. Multivariate regression and receiver operating characteristic (ROC) analysis was used to evaluate the predictive value of thrombus volume and density for PE. RESULTS: Of the included 145 patients (mean age=41.7 ± 10.3 years), there were 87 patients in the DVT-only group and 58 patients in the DVT-PE group. The DVT-PE group showed a significantly higher DVT density (67.4 ± 8.6 HU vs. 57.3 ± 10.4 HU; P < 0.001) and larger DVT volume (16.4 ± 13.9 cm3 vs. 12.8 ± 10.1 cm3; P = 0.016) than the DVT-only group. On multivariate analysis, thrombus density was the only associated factor for PE. ROC analysis showed that thrombus density ≥61.8 HU was the optimal cutoff for predicting PE with an area under the curve (AUC) of 0.774 and thrombus volume ≥14.0 cm3 was the cutoff with an AUC of 0.638. CONCLUSION: Though the results of our study should be considered within the limitations, DVT density could be a predictor for acute PE. Further studies are needed to clarify the clinical value of quantitative features of DVT including thrombus volume as an imaging biomarker for PE.